Axiogenesis

Cologne - Germany

Axiogenesis provides in vitro differentiated cardiomyocytes, endothelial cells and smooth muscle cells for drug development and toxicological testing. The cells are derived from embryonic or induced pluripotent stem cells and are 100% pure and homogeneous. A range of assays using these cells is available, with the option of client-specific customization. Assays can also be performed in-house.